Document:

EX-10.3

 Exhibit 10.3 

HUMANA INC. 

EXECUTIVE SEVERANCE POLICY 

This Humana Inc. Executive Severance Policy has been adopted by the Organization & Compensation Committee (the
“Committee”) of the Board of Directors of the Company to apply to selected executive employees of the Company. Executives will be eligible for coverage under the Policy for the payment of severance benefits upon termination of
employment under certain circumstances, subject to the conditions set forth below. This Policy shall be effective as of the Effective Date as provided herein. 

1.    Definitions. For purposes of this Policy, the following terms shall have the following meaning: 

“Annual Base Salary” shall mean an Executive’s stated annual compensation without regard to any bonus, perquisite or
other benefits. 
 “Annual Bonus” means the annual bonus or incentive compensation payable to Executive under the
Company’s annual bonus or incentive compensation program in which Executive participates from time to time. 
 “Cause”
means (i) a felony conviction of Executive, (ii) the failure of Executive to contest prosecution for a felony, or (iii) Executive’s willful misconduct or dishonesty, any of which is determined by the Compensation Committee to be
directly and materially harmful to the business or reputation of the Company or any of its subsidiaries. 
 “CEO” shall
mean the Company’s President and Chief Executive Officer. 
 “CEO Direct Reports” shall mean Executive Officers of the
Company who are direct reports to the Company’s President and Chief Executive Officer. 
 “Company” means Humana Inc.,
a Delaware corporation. 
 “Code” means the Internal Revenue Code of 1986, as amended. 

“Compensation Committee” means the Organization and Compensation Committee of the Board of Directors of the Company. 

“Date of Termination” means the effective date of the relevant Executive’s termination of employment with the Company.

 “Effective Date” means January 1, 2019, or such later date as determined by the Compensation Committee with respect
to an Executive. 
 “Executive” means Executive Officers of the Company (including the CEO) and such other individuals as
identified by the Compensation Committee, in each case employed by the Company or an affiliate of the Company on a full-time or part-time basis. Individuals will continue to be deemed an “Executive” eligible for the rights and benefits
under this Policy for a period of twelve (12) months following a change in role or title at the Company that would otherwise have caused the individual to cease to be an eligible Executive Officer or other individual identified by the
Compensation Committee as eligible. 

 “Executive Officer” shall include those executive officers designated by
the Board under Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended. 

“Policy” means this Humana Inc. Executive Severance Policy. 

“Separation from Service” means a termination of the employment relationship of the Executive with the Company or an
affiliate within the meaning of Section 409A of the Code and Treasury Regulation section 1.409A-1(h) or any successor thereto. 

“Severance Period” means (i) for the CEO, twenty-four (24) months following the Date of Termination, (ii) for
CEO Direct Reports, eighteen (18) months following the Date of Termination and (iii) for all other Executives, six (6) months plus two (2) weeks per year of completed service. 

“Severance Rate” means (i) for the CEO, the CEO’s then current Annual Base Salary plus the target annual bonus or
incentive compensation which could have been earned by the CEO, calculated as if all relevant goals had been met during the Company’s then-current fiscal year pursuant to the terms of the incentive compensation plan in which the CEO
participates, and (ii) for all of Executives, such Executive’s then current Annual Base Salary. 

2.    Term of Policy. The term of this Policy shall begin on the Effective Date and shall continue in effect until
modified or terminated by the Company pursuant to Section 13 hereof. 
 3.    Termination. The Company may
terminate the employment of Executive for any reason and at any time. In the event that the Company terminates the employment of Executive without Cause, Executive shall be entitled to the following rights and benefits under this Section 3:

 3.1    Severance Benefits. Subject to Executive’s compliance with all terms of this Policy, including,
without limitation, Sections 5 and 6 hereof: 
 (i)    Salary Continuation Payments. The Company will pay
Executive salary continuation through the Severance Period at an annual rate equal to such Executive’s Severance Rate; provided that any payments that would otherwise be paid during the Severance Period that remain outstanding as of
March 15 of the year following the year during which the Date of Termination occurred shall be paid in a lump sum on such date. Salary continuation under this Section 3.1 shall be paid on a bi-weekly
basis in accordance with the Company’s customary payroll practices with the first payment to be made in accordance with Section 5 hereof, subject to the accelerated payment of the remaining amounts in accordance with the prior sentence.

 (ii)    Pro-Rata Bonus. The Company will pay Executive an amount equal
to the product of (A) the Annual Bonus, if any, that Executive would have earned for the calendar year in which the Date of Termination occurs, based on achievement of the applicable 

 
performance goals for each such calendar year, as uniformly applied to other Executives who remain employed through the end of the applicable performance period and (B) a fraction, the
numerator of which is the number of days Executive was employed by the Company during the calendar year of termination, and the denominator of which is the number of days in such calendar year. This amount shall be paid on the date that Annual
Bonuses are normally paid, but in no event later than March 15th of the year following the year in which the Date of Termination occurs. 

(iii)    Continued Health Benefit Coverage. The Company will provide to each Executive and Executive’s
eligible dependents, through the end of the (i) applicable Severance Period for such Executive, or (ii) the effective date of Executive’s coverage under equivalent benefits from a new employer (provided that no such equivalent
benefits shall be considered effective unless and until all pre-existing condition limitations and waiting period restrictions have been waived or have otherwise lapsed), at the Compensation Committee’s
option, either (A) continued medical and dental coverage under the Company’s health care plan at the same level of coverage to which such Executive was entitled on the Date of Termination, subject to eligibility requirements and other
conditions contained in the plan, including the requirement that Executive continue to pay the “employee portion” of the cost thereof, or (B) equivalent benefits (or equivalent cash value, payable on an
after-tax basis), as determined in the sole reasonable discretion of the Compensation Committee. The coverage provided pursuant to this Section 3.1(iii) shall be in satisfaction of the Company’s
obligation to provide coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA). 

(iv)    Outplacement Services; Financial Planning. The Company will provide an Executive who is the CEO or a CEO
Direct Report or otherwise designated by the Committee (i) with financial planning services during the one year period immediately following the Date of Termination on the same terms as the financial planning services were provided to such
Executive immediately prior to the Date of Termination, and (ii) with outplacement services through an outplacement firm of the Company’s choosing at a level of services to be determined by the Company, with such services to extend until
the earlier of (A) one year following the Date of Termination or (B) the date Executive secures full time employment. 

3.2    Accrued Rights. Within fifteen (15) business days following the Date of Termination, the Company will
pay or provide Executive with (i) all accrued but unpaid base salary through the Date of Termination, (ii) vacation pay accrued but not used in accordance with the Company’s vacation pay policy, (iii) any previously awarded but
unpaid Annual Bonus for a completed calendar year prior to the Date of Termination, (iv) any unreimbursed business expenses that are reimbursable under the Company’s business expense policy, and (v) all rights and benefits under the
employee benefit plans of the Company in which Executive is then participating, (collectively, the “Accrued Rights”). 

3.3    No Additional Rights. Except as provided in this Section 3, Executive’s participation under any
benefit plan, program, policy or arrangement sponsored or maintained by the Company shall be treated in accordance with the terms of the applicable plan. Without limiting the generality of the foregoing, Executive’s eligibility for and active
participation in any of the retirement plans maintained by the Company will end on the Date of Termination and Executive will earn no additional benefits, including, without limitation, any additional service

 
credit, under those plans after that date. Executive shall be treated as a terminated employee for purposes of all such benefit plans and programs effective as of the Date of Termination, and
shall receive all payments and benefits due under such plans and programs in accordance with the terms and conditions thereof. 

4.    Other Terminations. The Company may terminate the employment of Executive for any reason and at any time. In
the event that the Company terminates the employment of Executive during the term of the Policy, other than a termination of employment by the Company for Cause, the Company will pay or provide Executive with all Accrued Rights. Executive may
terminate his or her employment for any reason and at any time and shall not be entitled to any payments or benefits under this Policy by reason of such termination of employment from the Company. This Policy shall have no effect on the rights and
benefits to which an Executive is entitled upon retirement under (without limitation) any retirement or savings plan of the Company, which shall be governed exclusively by the terms of such plans and agreements, as applicable. 

5.    Release. 

5.1    As a condition precedent to receiving the payments and benefits as provided herein, Executive will execute (and not
revoke) a general release of claims (the “Release”), in a form provided by the Company. If Executive fails to execute and deliver the Release, or revokes the Release, Executive agrees that he shall not be entitled to receive the
payments and benefits described herein. For purposes of this Policy, the Release shall be considered to have been executed by Executive if it is signed by Executive’s legal representative in the case of legal incompetence or on behalf of
Executive’s estate in the case of Executive’s death. 
 5.2    Except as otherwise specified or agreed to by
Executive and the Company, payment of any amounts described hereunder that are subject to the Release will begin on the 60th day following the Date of Termination, with the first such payment to include any amounts attributable to payroll intervals
occurring prior to such date, provided, however, that, to the extent that the payments are exempt from Section 409A of the Code, such exempt payments shall be made beginning with the first payroll date following the effectiveness of the
Release. 
 6.    Restrictive Covenants. In consideration of Executive’s employment by the Company and the
rights and benefits of Executive provided by this Policy, Executive will enter into agreements that contain certain covenants regarding non-competition,
non-solicitation, non-disparagement and specific enforcement with the restricted period for the non-competition and non-solicitation covenants to be the applicable Severance Period for such Executive, commencing upon the Date of Termination. With respect to the CEO, in consideration of the CEO’s employment by the Company and
the rights and benefits of the CEO provided by this Policy, CEO hereby agrees to the restrictive covenants set forth in Exhibit B hereto, effective as of the date of execution by the CEO of the acknowledgement attached as Exhibit A hereto
(the “Restrictive Covenants Effective Date”). 

 7.    Section 409A. 

7.1    Compliance. It is intended that this Policy be exempt from the provisions of Section 409A of the Code
and this Policy shall be construed, administered, and governed in a manner consistent with this intent. If and to the extent that any payment or benefit under this Policy is determined by the Company to constitute
“non-qualified deferred compensation” subject to Section 409A of the Code and is payable to Executive by reason of Executive’s termination of employment, then such payment or benefit shall
be made or provided to Executive only upon a Separation from Service as defined for purposes of Section 409A of the Code. Each severance payment under this Policy will be considered a “separate payment” and not one of a series of
payments for purposes of Section 409A of the Code. To the extent that any benefits to be provided to Executive pursuant to this Policy are considered nonqualified deferred compensation and are reimbursements subject to Treasury Regulation Section 1.409A-3(i)(1)(iv), then (i) the reimbursement of eligible expenses related to such benefits shall be made on or before the last day of the Executive’s taxable year following the
Executive’s taxable year in which the expense was incurred and (ii) notwithstanding anything to the contrary in this Policy or any plan providing for such benefits, the amount of expenses eligible for reimbursement during any taxable year
of the Executive shall not affect the expenses eligible for reimbursement in any other taxable year. Nothing in this Policy will provide a basis for any person to take action against the Company or its affiliates based on matters covered by
Section 409A of the Code and in no event will the Company or its affiliates be liable for any additional tax, interest or penalties that may be imposed on Executive under Section 409A of the Code or any damages for failing to comply with
Section 409A of the Code. 
 7.2    Six Month Delay for Specified Executives. To the extent that any amount
payable or benefit to be provided under this Policy constitutes a nonexempt “nonqualified deferred compensation plan” (as defined in Section 409A of the Code) upon a Separation from Service, and to the extent an Executive is deemed to
be a “specified employee” (as that term is defined in Section 409A of the Code and pursuant to procedures established by the Company) on the Date of Termination, notwithstanding any other provision in this Policy to the contrary, such
payment or benefit provision will not be made to the Executive during the six month period immediately following the Date of Termination. Instead, on the first day of the seventh month following the Date of Termination, all amounts that otherwise
would have been paid or provided to the Executive during the six month period, but were not paid or provided because of this Section 7.2, will be paid or provided to the Executive at such time without interest. This six month delay will cease
to be applicable if the Executive incurs a Separation from Service due to death or if the Executive dies before the six month period has expired. 

8.    Withholding Taxes. All compensation payable pursuant to this Policy shall be subject to reduction by all
applicable withholding, social security and other federal, state and local taxes and deductions, and the Company shall be authorized to make all such withholdings to the extent it determines necessary under applicable law. 

9.    Acknowledgment. Executive acknowledges that this Policy does not constitute a contract of employment or
impose on the Company any obligation to retain Executive as an employee and that this Policy does not prevent Executive from terminating employment at any time. 

 10.    Non-Duplication of
Benefits; CIC Policy. The severance benefit under this Policy is not intended to duplicate any other benefits provided by the Company in connection with the termination of an employee’s employment, such as wage replacement benefits, pay-in-lieu-of-notice, severance pay, or similar benefits under any other benefit plans,
severance programs, employment contracts, or applicable federal or state laws, such as the WARN Acts. Should such other benefits be payable, the severance benefit under this Policy will be reduced accordingly or, alternatively, severance benefits
previously paid under this Policy will be treated as having been paid to satisfy such other benefit obligations. In either case, the Company will determine how to apply this provision and may override other provisions in this Policy in doing so. In
addition, and notwithstanding anything else provided herein, to the extent Executive is entitled to severance payments and benefits upon termination of employment pursuant to the Company’s Change in Control Policy or any other change in control
arrangements, this Policy will cease to apply and Executive’s entitlement to severance benefits shall be governed solely by the Change in Control Policy. 

11.    Administration. The Compensation Committee is responsible for the administration of this Policy and shall
have all powers and duties necessary to fulfill its responsibilities. The Compensation Committee shall determine any and all questions of fact, resolve all questions of interpretation of the Policy which may arise, and exercise all other powers and
discretion necessary to be exercised under the terms of the Policy which it is herein given or for which no contrary provision is made. The Compensation Committee shall have full power and discretion to interpret the Policy and related documents, to
resolve ambiguities, inconsistencies and omissions, to determine any question of fact, and to determine the rights and benefits, if any, of any Executive or other employee, in accordance with the provisions of the Policy. The Compensation
Committee’s decision with respect to any matter shall be final and binding on all parties concerned. The validity of any such interpretation, construction, decision, or finding of fact shall not be given de novo review if challenged in court,
by arbitration, or in any other forum, and shall be upheld unless clearly arbitrary or capricious. The Compensation Committee may, from time to time, by action of its appropriate officers, delegate to designated persons or entities the right to
exercise any of its powers or the obligation to carry out its duties under the Policy. 
 12.    Amendment and
Termination. The Company reserves the right to amend or terminate this Policy at any time and in any manner, without consent or advance notice to Executives or other employees. No amendment or termination of the Policy shall affect the rights of
an Executive whose Date of Termination has occurred prior to the date of such amendment or termination of the Policy and who remains entitled to severance payments or benefits under this Policy. 

 Exhibit A 

Acknowledgment 
 I
acknowledge that I received, read and understand the Humana Inc. Executive Severance Policy (the “Policy”), which supersedes all prior agreements, programs and arrangements with Humana Inc., written or oral, relating to the subject
matter hereof, including the terms of any offer letter agreements, as amended from time to time. In the event of any inconsistency, the terms of the Policy will govern. For the avoidance of doubt, the Policy will not have any impact on the treatment
of any outstanding equity awards that I hold, which will continue to be treated in accordance with the terms and conditions set forth in the applicable award agreement or equity plan. I also acknowledge that the Policy extends additional benefits to
me that are not covered under existing agreements, programs and arrangements. This Acknowledgement is not an employment contract or a guarantee of continued employment. 
  

			
	  
	  	  

	Name:	  	Date:
	Title:	  	

 Exhibit B 

Restrictive Covenants 
 Confidential
Information and Trade Secrets 
 The Executive recognizes that the Executive’s position with the Company requires considerable responsibility and
trust, and, in reliance on the Executive’s loyalty, the Company may entrust the Executive with highly sensitive confidential, restricted and proprietary information involving Trade Secrets and Confidential Information. 

“Trade Secret” shall be defined as any scientific or technical information, design, process, procedure, formula or improvement that is
valuable and not generally known to competitors of the Company. “Confidential Information” is any data or information, other than Trade Secrets, that is important, competitively sensitive, and not generally known by the public,
including, but not limited to, the Company’s business plans, business prospects, training manuals, product development plans, bidding and pricing procedures, market strategies, internal performance statistics, financial data, confidential
personnel information concerning employees of the Company, supplier data, operational or administrative plans, policy manuals, and terms and conditions of contracts and agreements. The terms “Trade Secrets” and “Confidential
Information” shall not apply to information which is (i) already in the Executive’s possession (unless such information was used in connection with formulating the Company’s business plans, obtained by the Executive from the
Company or was obtained by the Executive in the course of the Executive’s employment by the Company), or (ii) required to be disclosed by any applicable law. 

Except as may be required by law or legal process or an order of a court of competent jurisdiction, the Executive will not use or disclose any Trade Secrets
or Confidential Information of the Company at any time after termination of employment and prior to such time as they cease to be Trade Secrets or Confidential Information through no act of the Executive in violation of this Section. 

Upon termination of employment, Executive will surrender to the Company all memoranda, notes, records, plans, manuals or other documents pertaining to the
Company’s business or the Executive’s employment (including all copies thereof). The Executive will also leave with the Company all materials involving Trade Secrets or Confidential Information of the Company. All such information and
materials, whether or not made or developed by the Executive, shall be the sole and exclusive property of the Company, and the Executive hereby assigns to the Company all of the Executive’s right, title and interest in and to any and all of
such information and materials. 
 Agreement Not to Compete and Agreement Not to Solicit 

The Executive hereby covenants and agrees that, for a period commencing on the Restrictive Covenants Effective Date and ending twenty-four (24) months
after the date of termination of Executive’s employment for any reason (the “Termination Date”), the Executive, directly or indirectly, personally, or as an employee, officer, director, partner, member, owner, stockholder,
investor or principal of, or consultant or independent contractor with, another entity, shall not participate in any business which competes with the Company including, without limitation, health maintenance

 
organizations, insurance companies or prepaid health plan businesses in which the Company has been actively engaged during any part of the two (2) year period immediately preceding the
Termination Date (“Company Business”), in any Geographic Area (as defined below) in which the Company and/or any of its Affiliates is then doing business. For purposes of this Employment Agreement, “Geographic Area”
means any state, commonwealth or territory of the United States or any equivalent entity in any foreign country. 
 The Executive hereby covenants and
agrees that, for a period commencing on the Restrictive Covenants Effective Date and ending twenty-four (24) months after the Executive’s Termination Date, the Executive, directly or indirectly, personally, or as an employee, officer,
director, partner, member, owner, stockholder, investor or principal of, or consultant or independent contractor with, another entity, shall not: (1) interfere with the relationship of the Company and any of its employees, agents,
representatives, consultants or advisors; (2) divert, or attempt to cause the diversion from the Company, any Company Business, nor interfere with relationships of the Company with its policyholders, agents, brokers, dealers, distributors,
marketers, sources of supply or customers; or (3) solicit, recruit or otherwise induce or influence any employee of the Company to accept employment in any business which competes with the Company Business, in any Geographic Area in which the
Company and/or any of its Affiliates is then doing business.DIRECTOR
AGREEMENT

 

This
DIRECTOR AGREEMENT is made as of May 8, 2018 (the “Agreement”), by and between Sports Field Holdings, Inc., a Nevada
corporation (the “Company”), and John Tuntland, an individual with an address at [●] (the “Director”).

 

WHEREAS,
the Company appointed the Director on May 7, 2018 and desires to enter into an agreement with the Director with respect to such
appointment; and

 

WHEREAS,
the Director is willing to accept such appointment and to serve the Company on the terms set forth herein and in accordance with
the provisions of this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:

 

1.
Position. Subject to the terms and provisions of this Agreement, the Company shall cause the Director to be appointed,
and the Director hereby agrees to serve the Company in such position, upon the terms and conditions hereinafter set forth, provided,
however, that the Director’s continued service on the Board of Directors of the Company (the “Board”)
after the next annual stockholders’ meeting shall be subject to approval by a majority of the Company’s stockholders.

 

2.
Duties. (a) During the Directorship Term (as defined herein), the Director shall make reasonable business efforts to attend
all Board meetings, serve on appropriate subcommittees as reasonably requested by the Board, make himself available to the Company
at mutually convenient times and places, attend external meetings and presentations, as appropriate and convenient, and perform
such duties, services and responsibilities, and have the authority commensurate to such position.

 

(b)
The Director will use his reasonable best efforts to promote the interests of the Company. The Company recognizes that the Director
(i) is or may become a full-time executive employee of another entity and that his responsibilities to such entity must have priority
and (ii) sits or may sit on the board of directors of other entities. Notwithstanding the same, the Director will use reasonable
business efforts to coordinate his respective commitments so as to fulfill his obligations to the Company and, in any event, will
fulfill his legal obligations as a Director. Other than as set forth above, the Director will not, without the prior notification
to the Board, engage in any other business activity which could materially interfere with the performance of his duties, services
and responsibilities hereunder or which is in violation of the reasonable policies established from time to time by the Company,
provided that the foregoing shall in no way limit his activities on behalf of (i) any current employer and its affiliates
or (ii) the board of directors of any entities on which he currently sits. At such time as the Board receives such notification,
the Board may require the resignation of the Director if it determines that such business activity does in fact materially interfere
with the performance of the Director’s duties, services and responsibilities hereunder.

 

    	 

    	 

    

 

3.
Compensation.

 

(a)
Stock Options. The Director shall receive, upon execution of this Agreement, provided the Director is continuing to serve as a
director of the Company, a non-qualified stock option to purchase up to two hundred thousand (200,000) shares of the Company’s
common stock at an exercise price per share equal to $1.00. Such options shall be exercisable for a period of five years from
the date of granting. The options shall vest in equal amounts over a period of two (2) years at the rate of twenty-five thousand
(25,000) shares per fiscal quarter on the last day of each such quarter, commencing in the third fiscal quarter of 2018. Notwithstanding
the foregoing, if the Director ceases to be a member of the Board at any time during the two (2) year vesting period for any reason
(such as resignation, withdrawal, death, disability or any other reason), then any un-vested options shall be irrefutably forfeited.
Vested options shall remain exercisable for a period of five years after the date of granting. Vested options shall remain the
property of the Director even if the Director ceases to be a member of the Board for any reason at any time after the two year
vesting period. In the event of the Director’s death or incapacitation, Director’s heirs and assigns shall have full
rights to exercise the Director’s vested stock options during the period of five years after the date of granting of such
options.

 

(b)
Cash. The Director shall be paid One Thousand ($1,000) Dollars for each Board meeting that the Director attends in person (rather
than via telephone or other remote access).

 

(c)
Independent Contractor. The Director’s status during the Directorship Term shall be that of an independent contractor and
not, for any purpose, that of an employee or agent with authority to bind the Company in any respect. All payments and other consideration
made or provided to the Director under this Section 3 shall be made or provided without withholding or deduction of any kind,
and the Director shall assume sole responsibility for discharging all tax or other obligations associated therewith.

 

(d)
Expense Reimbursements. During the Directorship Term, the Company shall reimburse the Director for all reasonable out-of-pocket
expenses incurred by the Director in attending any in-person meetings, provided that the Director complies with the generally
applicable policies, practices and procedures of the Company for submission of expense reports, receipts or similar documentation
of such expenses. Any reimbursements for allocated expenses (as compared to out-of-pocket expenses of the Director) must be approved
in advance by the Company.

 

4.
Directorship Term. The “Directorship Term,” as used in this Agreement, shall mean the period commencing on
the date hereof and terminating on the earlier of the date of the next annual stockholders meeting and the earliest of the following
to occur:

 

(a)
the death of the Director;

 

(b)
the termination of the Director from his membership on the Board by the mutual agreement of the Company and the Director;

 

    	 	2	 

    	 

    

 

(c)
the removal of the Director from the Board by the majority stockholders of the Company; and

 

(d)
the resignation by the Director from the Board.

 

5.
Director’s Representation and Acknowledgment. The Director represents to the Company that his execution and performance
of this Agreement shall not be in violation of any agreement or obligation (whether or not written) that he may have with or to
any person or entity, including without limitation, any prior or current employer. The Director hereby acknowledges and agrees
that this Agreement (and any other agreement or obligation referred to herein) shall be an obligation solely of the Company, and
the Director shall have no recourse whatsoever against any officer, director, employee, stockholder, representative or agent of
the Company or any of their respective affiliates with regard to this Agreement.

 

6.
Director Covenants.

 

(a)
Unauthorized Disclosure. The Director agrees and understands that in the Director’s position with the Company, the Director
has been and will be exposed to and receive information relating to the confidential affairs of the Company, including, but not
limited to, technical information, business and marketing plans, strategies, customer information, other information concerning
the Company’s products, services, promotions, development, financing, expansion plans, business policies and practices,
and other forms of information considered by the Company to be confidential, and proprietary and in the nature of trade secrets.
The Director agrees that during the Directorship Term and thereafter, the Director will keep such information confidential and
will not disclose such information, either directly or indirectly, to any third person or entity without the prior written consent
of the Company; provided, however, that (i) the Director shall have no such obligation to the extent such information
is or becomes publicly known or generally known in the Company’s industry other than as a result of the Director’s
breach of his obligations hereunder and (ii) the Director may, after giving prior notice to the Company to the extent practicable
under the circumstances, disclose such information to the extent required by applicable laws or governmental regulations or judicial
or regulatory process. This confidentiality covenant has no temporal, geographical or territorial restriction. Upon termination
of the Directorship Term, the Director will promptly return to the Company and/or destroy at the Company’s direction all
property, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys,
maps, logs, machines, technical data, other product or document, and any summary or compilation of the foregoing, in whatever
form, including, without limitation, in electronic form, which has been produced by, received by or otherwise submitted to the
Director in the course or otherwise as a result of the Director’s position with the Company during or prior to the Directorship
Term, provided that the Company shall retain such materials and make them available to the Director if requested by him
in connection with any litigation against the Director under circumstances in which (i) the Director demonstrates to the reasonable
satisfaction of the Company that the materials are necessary to his defense in the litigation and (ii) the confidentiality of
the materials is preserved to the reasonable satisfaction of the Company.

 

    	 	3	 

    	 

    

 

(b)
Non-Solicitation. During the Directorship Term and for a period of three (3) years thereafter, the Director shall not interfere
with the Company’s relationship with, or endeavor to entice away from the Company, any person who, on the date of the termination
of the Directorship Term and/or at any time during the one year period prior to the termination of the Directorship Term, was
an employee or customer (including those reasonably expected to be a customer) of the Company or otherwise had a material business
relationship with the Company.

 

(c)
Remedies. The Director agrees that any breach of the terms of this Section 6 would result in irreparable injury and damage to
the Company for which the Company would have no adequate remedy at law. The Director therefore also agrees that in the event of
said breach or any threat of breach, the Company shall be entitled to an immediate injunction and restraining order to prevent
such breach and/or threatened breach and/or continued breach by the Director and/or any and all entities acting for and/or with
the Director, without having to prove damages or paying a bond, in addition to any other remedies to which the Company may be
entitled at law or in equity. The terms of this paragraph shall not prevent the Company from pursuing any other available remedies
for any breach or threatened breach hereof, including, but not limited to, the recovery of damages from the Director. The Director
acknowledges that the Company would not have entered into this Agreement had the Director not agreed to the provisions of this
Section 6.

 

(d)
The provisions of this Section 6 shall survive any termination of the Directorship Term, and the existence of any claim or cause
of action by the Director against the Company, whether predicated on this Agreement or otherwise, shall not constitute a defense
to the enforcement by the Company of the covenants and agreements of this Section 6.

 

7.
Indemnification. The Company agrees to indemnify the Director for his activities as a member of the Board as set forth
in the Director and Officer Indemnification Agreement attached hereto as Exhibit A.

 

8.
Non-Waiver of Rights. The failure to enforce at any time the provisions of this Agreement or to require at any time performance
by the other party hereto of any of the provisions hereof shall in no way be construed to be a waiver of such provisions or to
affect either the validity of this Agreement or any part hereof, or the right of either party hereto to enforce each and every
provision in accordance with its terms. No waiver by either party hereto of any breach by the other party hereto of any provision
of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions at that time
or at any prior or subsequent time.

 

9.
Notices. Every notice relating to this Agreement shall be in writing and shall be given by personal delivery, overnight
delivery or by registered or certified mail, postage prepaid, return receipt requested; to:

 

    	 	4	 

    	 

    

 

If
to the Company:

 

Sports
Field Holdings, Inc.

1020
Cedar Ave, Suite 230

St.
Charles, IL 60174

Attn:
Jeromy Olson

Telephone:
(978) 914-7570

 

with
a copy (which shall not constitute notice) to:

 

Baker
McKenzie

300
E Randolph St, Suite 500

Chicago,
IL 60601

Attn:
Sali Wissa

Telephone:
(312) 861-8000

 

If
to the Director:

 

John
Tuntland

[●]

 

Either
of the parties hereto may change their address for purposes of notice hereunder by giving notice in writing to such other party
pursuant to this Section 9.

 

10.
Binding Effect/Assignment. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their
respective heirs, executors, personal representatives, estates, successors (including, without limitation, by way of merger) and
assigns, as applicable. Notwithstanding the provisions of the immediately preceding sentence, neither the Director nor the Company
shall assign all or any portion of this Agreement without the prior written consent of the other party.

 

11.
Entire Agreement. This Agreement (together with the other agreements referred to herein) sets forth the entire understanding
of the parties hereto with respect to the subject matter hereof and supersedes all prior agreements, written or oral, between
them as to such subject matter.

 

12.
Severability. If any provision of this Agreement, or any application thereof to any circumstances, is invalid, in whole
or in part, such provision or application shall to that extent be severable and shall not affect other provisions or applications
of this Agreement.

 

13.
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York,
without reference to the principles of conflict of laws. All actions and proceedings arising out of or relating to this Agreement
shall be heard and determined in any court in the State of New York and the parties hereto hereby consent to the jurisdiction
of such courts in any such action or proceeding; provided, however, that neither party hereto shall commence any
such action or proceeding unless prior thereto the parties have in good faith attempted to resolve the claim, dispute or cause
of action which is the subject of such action or proceeding through mediation by an independent third party.

 

    	 	5	 

    	 

    

 

14.
Legal Fees. The parties hereto agree that the non-prevailing party in any dispute, claim, action or proceeding between
the parties hereto arising out of or relating to the terms and conditions of this Agreement or any provision thereof (a “Dispute”),
shall reimburse the prevailing party for reasonable attorney’s fees and expenses incurred by the prevailing party in connection
with such Dispute; provided, however, that the Director shall only be required to reimburse the Company for its
fees and expenses incurred in connection with a Dispute if the Director’s position in such Dispute was found by the court,
arbitrator or other person or entity presiding over such Dispute to be frivolous or advanced not in good faith.

 

15.
Modifications. Neither this Agreement nor any provision hereof may be modified, altered, amended or waived except by an
instrument in writing duly signed by the party to be charged.

 

16.
Tense and Headings. Whenever any words used herein are in the singular form, they shall be construed as though they were
also used in the plural form in all cases where they would so apply. The headings contained herein are solely for the purposes
of reference, are not part of this Agreement and shall not in any way affect the meaning or interpretation of this Agreement.

 

17.
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original
but all of which together shall constitute one and the same instrument.

 

[-Signature
Page Follows-]

 

    	 	6	 

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Director Agreement to be executed by authority of its Board of Directors, and the
Director has hereunto set his hand, on the day and year first above written.

 

	SPORTS FIELD HOLDINGS, INC.	 
	 	 	 
	By:	/s/
    Jeromy Olson	 
	 	Jeromy
    Olson	 
	 	Chief
Executive Officer	 
	 	 	 
	DIRECTOR	 
	 	 	 
	/s/
    JOHN TUNTLAND	 
	JOHN TUNTLAND, an individual	 

 

[Signature page to Director Agreement]

 

    	 

    	 

    

 

EXHIBIT
A

 

DIRECTOR
AND OFFICER INDEMNIFICATION AGREEMENT

 

(attached)

 

[Exhibit A to Director Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]